Bank Of America Corp Beam Therapeutics Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 136,933 shares of BEAM stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,933
Previous 539,987
74.64%
Holding current value
$2.5 Million
Previous $13.2 Million
74.34%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BEAM
# of Institutions
259Shares Held
84.9MCall Options Held
482KPut Options Held
230K-
Vanguard Group Inc Valley Forge, PA8.87MShares$162 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.48MShares$155 Million1.79% of portfolio
-
Farallon Capital Management LLC San Francisco, CA8.24MShares$150 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$139 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$82.8 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.28B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...